SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALATOSIDASE A

The invention relates, in part, to improved methods of administering a-galactosidase A for the treatment of a-galactosidase A deficiencies including Fabry disease. L'invention porte, en partie, sur des procédés améliorés d'administration d'a-galactosidase A pour le traitement de défic...

Full description

Saved in:
Bibliographic Details
Main Authors NGUYEN, VIHN, SHAHROKH, ZAHRA, STURK, LISA, MARIE, TAYLOR, KATHERINE, D, LAMSA, JUSTIN, C, HEARTLEIN, MICHAEL, W
Format Patent
LanguageEnglish
French
Published 12.03.2009
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates, in part, to improved methods of administering a-galactosidase A for the treatment of a-galactosidase A deficiencies including Fabry disease. L'invention porte, en partie, sur des procédés améliorés d'administration d'a-galactosidase A pour le traitement de déficit en a-galactosidase A, comprenant la maladie de Fabry.
Bibliography:Application Number: WO2008US10212